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Gene expression and identification of gene therapy targets in nephropathy that eventually results in end-stage renal
diabetic nephropathy. A number of novel genes that are up- failure [1]. To begin with, hyperglycemia, conceivably,
regulated in diabetic kidneys have been identified. Recently, induces a phenotypic change in cells of the renal glomer-transforming growth factor- (TGF-)–driven secreted pro-
ulus [2] with an increase in the mRNA expression andteins, i.e., connective tissue growth factor (CTGF) and gremlin,
accentuated bioactivity of certain cytokines and growthwere identified. They are up-regulated in kidneys of diabetic
animals and modulate the biology of mesangial cells. CTGF factors, e.g., transforming growth factor-1 (TGF-1).
mediates TGF-–induced matrix overproduction by the mes- The latter seems to profoundly modulate the synthesis
angial cells. Gremlin is a putative antagonist of bone morphoge- of various extracellular matrix (ECM) glycoproteins [3],netic protein-2 that blocks mesangial cell proliferation. Thus,
and basically glomerulosclerosis reflects an accumulationgremlin may modulate the biology of mesangium by stimulating
mesangial cell proliferation and in turn production of matrix. of the such proteins, i.e., type I, III and IV collagens, fi-
In addition, transcriptionally regulated kinases, serum gluco- bronectin, laminin and proteoglycans [4]. The hypergly-
corticoid-regulated kinase and munc-13 have been identified. cemia-induced renal pathological alterations may also
The former stimulates renal tubular Na transport and is in-
be due to the accretion of non-enzymatic advanced glyca-volved in hyperfiltraion of diabetic kidneys by a Na transport
tion end-products (AGEs) [5], oxidation of glycoproteinsfeedback mechanism. Munc-13 has been shown to induce apo-
ptosis in hyperglycemic state via diacylglycerol-activated, PKC- by reactive oxygen species, intracellular accumulation of
independent signaling pathway. Another pathway relevant to sorbitol generated via reduction of glucose by aldose re-
diabetic nephropathy is polyol pathway, where glucose is re- ductase [6] and activation of protein kinase C (PKC) [7].duced to sorbitol by aldose reductase. Recently, a renal-specific
In addition, hemodynamic changes, including glomerularreductase of the aldo-keto reductase family was isolated. It is
hyperfiltration or glomerular hypertension, are also in-up-regulated in diabetic mice, and this could serve as a suitable
target for gene therapy in renal complications of diabetes. Sev- volved in the progression of diabetic nephropathy [8, 9].
eral mitochondrial genome-encoded genes, such as, cytochrome In mammalian tissues, mRNA expression, related to
oxidase and NADH dehydrogenase, are up-regulated in diabetic
the transcriptional activity of genes, is in a state of tre-kidneys. A novel nuclear-encoded mitochondrial gene, i.e., trans-
mendous dynamic turnover in various developmental andlocase inner mitochondrial membrane 44 (Tim44), is up-regu-
lated in diabetic kidneys, and it may also serve as another pathophysiological states. In such states, some of the genes
target for molecular therapeutic intervention at the core stor- are differentially expressed, and the isolation of such
age energy sites, i.e., mitochondria. In this review, these novel genes should enable one to identify potential pharmaco-differentially regulated genes that respond to hyperglycemic
logical or molecular therapeutic agents to be targeted atstress are described, and they may serve as possible targets for
various levels of a given disease process. Current esti-gene therapy in the treatment of diabetic nephropathy.
mate suggests that the human genome encodes 40,000
transcripts and only25% of the genes have been cloned
so far, and most of the novel genes need to be identified
and characterized. To isolate such novel genes, severalINTRODUCTION
molecular cloning techniques have been developed, in-
In type 1 and type 2 diabetes mellitus, chronic hyper- cluding subtractive hybridization [10], differential dis-
glycemia causes irreversible changes in the kidney, such play RT-PCR [11], representational difference analysis
as, glomerulosclerosis, tubular atrophy and interstitial of cDNA (cDNA-RDA) [12, 13]. In addition to cDNA
fibrosis, and they are collectively described as diabetic subtraction methods, efforts have been made to survey
gene expression profile by sequencing a large scale of
Key words: aldo-keto reductase, mitochondrial translocase. cDNA libraries [14, 15], or 9–10 bp cDNA tags, i.e., serial
analysis of gene expression (SAGE) [16], DNA filter 2002 by the International Society of Nephrology
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array and DNA microarray [17]. A number of novel angial cells. Therefore, it is essential to identify those
molecules that modulate the activity of TGF- or in turngenes that are differentially expressed have been isolated
and partially characterized. Their differential expression whose activities are influenced by TGF-1 whether in
an autocrine or paracrine fashion, so that their potentialraises the possibility that they may serve as potential
novel targets for molecular intervention, i.e., gene ther- use as candidates for gene therapy can be explored in
diabetic nephropathy.apy. In this brief review, a survey of such novel genes
isolated in our laboratory and by others that could serve
as possible candidates for targeting gene therapy in the
PROTEIN KINASES
amelioration of diabetic nephropathy is described.
Protein kinases play a pivitol role in signal transduc-
tion pathways, and the effect of hyperglycemia on mesan-
GROWTH FACTORS gial cell proliferation and matrix accumulation seems to
be mediated by serine/threonine protein kinases, i.e.,Since the description of the role of TGF- in diabetic
nephropathy many years ago several other molecules protein kinase C and cyclin-dependent kinase-2 [25]. The
activity of the kinases is largely dependent upon post-that are relevant in the pathogenesis of renal lesions
have been identified [18]. Interestingly, their biology is translational modifications, i.e., phosphorylation. In ad-
dition, transcriptional regulation influences the activityinter-linked to the multi-functionality of the TGF-, that
is, either their expression is modulated by TGF-1 or its of the kinases, including the “polo” subfamily of serine/
threonine kinases [26].expression is regulated by the molecules that are in-
volved in the pathogenesis of diabetic nephropathy. The Serum glucocorticoid-regulated kinase (Sgk), a puta-
tive serine/threonine protein kinase, is also transcription-various molecules that are relevant here include connec-
tive tissue growth factor (CTGF), bone morphogenetic ally regulated by certain serum factors, glucocorticoids,
and follicle-stimulating hormone. The Sgk has been re-protein-2 (BMP-2) and BMP-4, and IHG-2 (increased
in high glucose-2) gene, the latter being a part of the ported to be up-regulated in obese db/db mouse kidneys,
as assessed by differential display PCR [27, 28]. Sgk is3-untranslated region of gremlin.
The CTGF is one of the seven cysteine-rich secreted highly expressed in the mesangial and interstitial cells,
and cells in the thick ascending limbs of Henle’s loopproteins that comprise the CTGF family. It is a 38 kD
peptide secreted by cultured endothelial cells and fibro- and distal tubules, and it is significantly increased in
diabetic nephropathy [28]. In the lower nephron, it stimu-blasts that are exposed to TGF-. Suppression subtractive
hybridization revealed that CTGF is up-regulated in hu- lates renal tubular Na transport by enhancing the activ-
ity of various molecules, such as, renal epithelial Naman mesangial cells exposed to high concentrations of glu-
cose, i.e., 30 mM versus 5 mM, and also in renal glomeruli channel (ENaC), thick ascending limb Na, K, 2Cl
co-transporter (BSC-1). An increase in the activity ofisolated from streptozotocin (STZ)-induced diabetic rats
[19]. High concentration of glucose in the medium up- BSC-1 is expected to decrease the delivery of NaCl to the
macula densa, and that in turn enhances the glomerularregulates mesangial CTGF expression via TGF-1 and
protein kinase C-dependent pathways, and thus, it seems filtration rate. The hyperfiltration is one of the early
events in diabetic nephropathy that has been shown tothat CTGF seems to be a mediator of TGF--driven
ECM overproduction in diabetic nephropathy [19, 20]. accelerate its progression by perturbing the mesangial
cell function, and thus it seems that Sgk is also a criticalAnother TGF--driven novel secreted protein is gremlin
(IHG-2) that was identified in human mesangial cells molecule that could be of worthy consideration in the
development of new molecular therapeutics.exposed to high glucose concentration in the culture
medium [19, 21]. Gremlin, together with DAN and cer- Recently, a novel class of signaling proteins that be-
long to the protein kinase C (PKC) family but lack kinaseberus, are members of the cysteine knot superfamily of
proteins that have been shown to play a role in limb activity has been identified. Unc-13 is one of the mem-
bers of this unique superfamily, and it encodes a phorboldevelopment and neural crest cell differentiation [22, 23].
Both hyperglycemia and mechanical strain induce grem- ester/diacylglycerol (DAG)-binding protein in Caeno-
rhabditis elegans. Mammalian homologs, munc13-1, -2,lin expression in mesangial cells in culture, which in part
is TGF-1-mediated [21]. The gremlin-induced mesan- and -3, were originally cloned from rat brain, and they
share both DAG- and Ca2-binding domains. Munc13gial cell proliferation in diabetic nephropathy may be
inter-linked to the biology BMPs. Gremlin is a putative was also isolated from human mesangial cells grown in
high glucose media, using differential display PCR [29].antagonist BMP-2 and -4. BMP-2 has been shown to
block the mesangial cell proliferation triggered by epi- Munc13 is a cytoplasmic protein that is translocated to
Golgi saccules, and it induces apoptosis following diacyl-dermal and platelet derived growth factors [24]. Thus,
it is conceivable that a blockade of the effects of BMPs glycerol-dependent phorbol ester stimulation. Apoptosis
in the mesangium has been reported in the hyperglyce-would lead to gremlin-induced proliferation of the mes-
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Fig. 1. Flow-chart of diagram depicting vari-
ous steps of representational difference analy-
sis (RDA) of cDNA. The superscript Roman
letters indicate the number of cycles for hy-
bridization and amplification of cDNA-RDA.
For instance, in the first cycle, TesterI is ligated
to JI-linker, hybridized with driver with a ratio
of 1:100I to generate DP1I, difference product.
The fourth cycle to generate DP4IV may be nec-
essary if the agarose gel electrophoretogram
shows a heavy smear of high background DNA.
(reprinted from ref. # 13 with permission).
mic state, and it is believed to be mediated by munc13 ALR1B, a number of aldo-keto reductase (AKR) family
members have been identified in various tissues. AKRsthat exerts its effect via diacylglycerol-activated PKC-
are a family of monomeric oxido-reductases that catalyzeindependent signaling pathway, and the latter could be
the NADPH-dependent reduction of a variety of ali-a suitable target for gene therapy intervention [30].
phatic and aromatic aldehydes and ketones. Under basal
conditions,3% of the glucose is handled via the polyol
POLYOL PATHWAY pathway, however, it increases to30% in diabetic states,
A perturbation in the polyol pathway is believed to and it is also associated with an enhanced expression of
be another mechanism that is relevant to the pathogene- ALR1B. Currently, it is believed that there is a strong
sis of diabetic nephropathy [31]. In this pathway, glucose cross-link between the polyol pathway and glycation of
is reduced by aldose reductase (ALR1B) to sorbitol by proteins that influences the pathogenesis of diabetic com-
using NADPH as hydrogen donor and then oxidized by plications. This cross-link seems to be related to the use
sorbitol dehydrogenease to fructose by using NAD as of methylglyoxal, a preferred substrate of ALR1B. The
hydrogen acceptor. ALR1B is not specific to kidney and methylglyoxal seems to be a bridge in the polyol pathway
and non-enzymatic glycation of the proteins, and suchit is expressed in a wide variety of tissues. In addition to
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Fig. 2. Northern blot analyses of differentially expressed genes in nor-
mal and diabetic mouse kidneys. Total RNA (30 g) from normal (N)
and diabetic (D) mouse kidneys was denatured with glyoxal, subjected
to 1% agarose gel electrophoresis, transferred to Nylon membranes, and
hybridized with [32P] dCTP radiolabeled cDNA fragments of differen-
tially expressed clones (clone # 1–9), and-actin. Seven genes had upregu-
lated expression. The transcripts of clone #7 and #8 were rarely expressed,
and did not yield any hybridization signal. Clone #9 is the renal specific
oxido-reductase, and clone 6 is the mammalian translocase of inner mito-
chondrial membrane (reprinted from ref. 35 with permission).
modified proteins have the tendency to accumulate in
various extracellular matrices that are typically seen in
Fig. 3. Panel A: Photomicrograph of in situ autoradiograms of kidneydiabetic nephropathy. In view of the above, our labora-
tissue sections hybridized with renal specific oxido-reductase riboprobe.
tory set out to search for other oxido-reductases that are The reducatse mRNA is exclusively expressed in tubules of the renal
cortex and is absent in the medulla and glomeruli (arrow). Panel B:specific to kidney and are modulated by the hyperglyce-
Photomicrograph of the kidney sections stained with renal specific anti-mic response. cDNA-RDA was performed on kidney
oxido-reductase antibody. The spatial protein expression of the reduc-
tissues harvested from the hyperglycemic versus nor- atse is similar to the mRNA message, and it is absent in the medulla
and glomeruli (arrow). Magnifications: A and B, X25. Panel C: Compari-moglycemic newborn mice as previously described [13]
son of amino acid sequence of aldo/keto reductase motifs. Motif se-
(Fig. 1). A number of genes were found to be up-regu- quences are boxed. The NADPH binding sites are bolded and under-
scored. M-ROR*, mouse renal specific oxido-reductase; M-17HSD,lated in kidneys of mice with STZ-induced diabetes
mouse 17-hydroxysteroid dehydrogenase; B-PGFS, bovine lung pros-(Fig. 2). Among these up-regulated genes, a novel gene taglandin F synthase; H-BABPDD, bile acid binding protein dihydrod-
belonging to the AKR family was isolated [32]. It was iol dehydrogenase; Frog-Rho, -crystallin; R-ALR, rat aldehyde reduc-
tase; M-ADR, mouse aldose reductase (reprinted from ref. 32 withexclusively expressed in the kidney. Both mRNA and
permission).
protein expression studies revealed that its distribution
was restricted to renal proximal tubules (Figs. 3A and 3B).
Unlike other AKR family members, including ALR1B,
its AKR-3 motif was located near N terminus (Fig. 3C). MITOCHONDRIA-RELATED GENES
Fluorescence quenching and reactive blue agarose chro- Recently, up-regulation of mitochondrial genome-
matography studies revealed that it binds to NADPH encoded genes, such as cytochrome oxidase I and III,
with high affinity. Since this oxido-reductase is exclu- and NADH dehydrogenase IV, have been described in
sively expressed in the kidney and is tubular-specific, diabetic rat [33] and in subtotally resected mouse kidney
one can anticipate that future studies on this molecule [34]. The discovery of translocase of inner mitochondrial
certainly would yield further clues as to the pathogenesis membrane-44 (Tim44) in the diabetic kidney, which fa-
of tubular lesions in diabetic nephopathy. The informa- cilitates protein import from the cytosol to mitochondria
tion thus generated would be very useful in the develop- [35], suggests it may be involved in the initial pathobio-
ment of some therapeutic tools for the amelioration of logical events in the diabetic nephropathy, i.e., oxidative
phosphorylation that is stimulated upon glucose entrydiabetic complications.
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that are involved in various diseases and this would aid
in the identification of disease resistant or susceptible
genes. In recent years, subtraction cloning methods have
been employed and novel genes that are relevant to
a given disease process have been identified. By these
methods, however, it is difficult to have a comprehensive
gene expression profile unless thousands of clones are
screened simultaneously. In this regard, recently com-
pleted human and mouse genome projects should greatly
enhance our ability to survey the transcriptional activities
of almost all the genes by DNA-macroarray or -micro-
array analyses. The genes that exhibit transcriptional
Fig. 4. Electron micrographs showing the immuno-localization of Tim44 regulation can serve as suitable candidates for the gene
in the mitochondrial cristae of COS7 cells transfected with pcDNA3.1/ therapy in a given disease process, e.g., in diabetic ne-TIM-FLAG construct. The cells were fixed and processed for immuno-
phropathy. Certainly, by the latter methods a number ofelectron microscopy. The electron microscopy sections were succes-
sively incubated with primary mouse anti-FLAG M2 monoclonal anti- differentially expressed novel genes would be identified,
body and secondary goat anti-mouse IgG antibody conjugated with however, some caution should be exercised since therecolloidal gold. The mitochondrial cristae of the transfected cells had
are no “Fast Track” methods for the identificationparacrystalline arrays or honeycomb-like appearance besides their nor-
mal configuration as internal ridges or finger-like protrusions of the of their functional significance in a given disease process.
inner membrane into the mitochondrial matrix (Panels A and B). A It is only by performing the functional studies that therelatively high concentration of immuno-gold particles is seen in the
relevant differentially expressed novel genes can be fur-honeycomb-like structures or paracrystalline arrays (arrowheads). Im-
muno-gold particles are also seen on the mitochondrial inner cristae as ther identified that would be suitable for the application
well (arrows). Magnifications: A  40,000; B  100,000; and C  in gene therapy.70,000 (reprinted from ref. 35 with permission).
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